Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Lewin

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Cancer Medicine|May 19, 2025
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian CohortJoseph Sia, Stephanie Tan, Narayan Mohanakrishnan, et al.
Cancer Medicine|February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature reviewElizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Cancer Research|June 22, 2016
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to TumorigenicitySamantha E Boyle, Clare G Fedele, Vincent Corbin, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in AustraliaJustine A Ellis, Vajiranee S Malalasekera, Christie Allan, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
Molecular Diagnosis & Therapy|November 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian LaboratoryAdel Shahnam, Catherine Mitchell, Christopher R McEvoy, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Cancer Medicine|May 19, 2025
Trends in Practice Patterns and Clinical Outcomes for Desmoid Tumors: A Large Single-Institutional Australian CohortJoseph Sia, Stephanie Tan, Narayan Mohanakrishnan, et al.
Cancer Medicine|February 18, 2022
Systemic treatments and outcomes in CIC-rearranged Sarcoma: A national multi-centre clinicopathological series and literature reviewElizabeth A Connolly, Vivek A Bhadri, Johnathon Wake, et al.
Pathology|March 28, 2025
The implementation of an RNA-based gene fusion assay into a diagnostic oncology department: an Australian perspectiveChristopher R McEvoy, Catherine Mitchell, Owen W J Prall, et al.
Cancer Research|June 22, 2016
CD271 Expression on Patient Melanoma Cells Is Unstable and Unlinked to TumorigenicitySamantha E Boyle, Clare G Fedele, Vincent Corbin, et al.
Journal of Adolescent and Young Adult Oncology|July 23, 2021
Systems-Level Change to Alleviate Barriers to Cancer Clinical Trial Access for Adolescents and Young Adults in AustraliaJustine A Ellis, Vajiranee S Malalasekera, Christie Allan, et al.
International Journal of Cancer|September 12, 2017
Identifying actionable variants using next generation sequencing in patients with a historical diagnosis of undifferentiated pleomorphic sarcomaJeremy Lewin, Swati Garg, Beatrice Y Lau, et al.
JCO Oncology Practice|June 16, 2023
Patterns of Relapse in Australian Patients With Clinical Stage 1 Testicular Cancer: Utility of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group Surveillance RecommendationsCiara Conduit, Jeremy Lewin, Andrew Weickhardt, et al.
JCO Clinical Cancer Informatics|January 18, 2019
Applying Radiomics to Predict Pathology of Postchemotherapy Retroperitoneal Nodal Masses in Germ Cell TumorsJeremy Lewin, Paul Dufort, Jaydeep Halankar, et al.
European Urology Focus|February 12, 2018
A New Model to Predict Benign Histology in Residual Retroperitoneal Masses After Chemotherapy in NonseminomaRicardo Leão, Madhur Nayan, Nahid Punjani, et al.
Molecular Diagnosis & Therapy|November 11, 2025
Clinical Utility of an RNA-based Gene Fusion Assay in Sarcoma for Diagnosis and Management: Experience in an Australian LaboratoryAdel Shahnam, Catherine Mitchell, Christopher R McEvoy, et al.
Pageof 8